Literature DB >> 20375891

Maternal sepsis: epidemiology, etiology and outcome.

Jeroen van Dillen1, Joost Zwart, Joke Schutte, Jos van Roosmalen.   

Abstract

PURPOSE OF REVIEW: Sepsis is a major cause of maternal death worldwide. Little is known on the incidence of severe maternal morbidity related to sepsis. In this review, we focus on new findings concerning epidemiology, etiology and outcome of maternal sepsis in low-income as well as high-income countries. RECENT
FINDINGS: It is estimated that puerperal sepsis causes at least 75,000 maternal deaths every year, mostly in low-income countries. Studies from high-income countries report incidence of maternal morbidity due to sepsis of 0.1-0.6 per 1000 deliveries. The causative microorganisms are generally polymicrobial with beta-haemolytic streptococci group A (GAS) often being the cause of severe cases of puerperal fever. The single most important risk factor for postpartum infection seems to be caesarean section, and prophylactic antibiotics during the procedure substantially reduce the infection risk. Improvements in service provision as promoted through the Surviving Sepsis Campaign can reduce the overall risk of mortality and morbidity from maternal sepsis in high-income as well as in low-income countries.
SUMMARY: Maternal sepsis is an infrequent, but important complication of pregnancy, childbirth and puerperium, resulting in significant maternal morbidity and mortality worldwide. Improved outcome is possible through improved service provision.

Entities:  

Mesh:

Year:  2010        PMID: 20375891     DOI: 10.1097/QCO.0b013e328339257c

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  60 in total

1.  Hospital and provider patient volumes, cesarean section rates, and early postpartum invasive methicillin-resistant Staphylococcus aureus infection.

Authors:  Andrea M Parriott; Joelle M Brown; Onyebuchi A Arah
Journal:  Am J Infect Control       Date:  2013-12-19       Impact factor: 2.918

2.  First do no harm: interventions during childbirth.

Authors:  Lauren Jansen; Martha Gibson; Betty Carlson Bowles; Jane Leach
Journal:  J Perinat Educ       Date:  2013

3.  A Mobile Genetic Element Promotes the Association Between Serotype M28 Group A Streptococcus Isolates and Cases of Puerperal Sepsis.

Authors:  Ira Jain; Poulomee Sarkar; Jessica L Danger; Josette Medicielo; Roshika Roshika; Gregory Calfee; Anupama Ramalinga; Cameron Burgess; Paul Sumby
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

Review 4.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

Review 5.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

6.  Severe Puerperal Sepsis-A Simmering Menace.

Authors:  Sheeba Marwah; Sonam R Topden; Manjula Sharma; Ritin Mohindra; Pratima Mittal
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 7.  Postpartum group a Streptococcus sepsis and maternal immunology.

Authors:  Katie L Mason; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2011-10-24       Impact factor: 3.886

8.  Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes.

Authors:  Elyara M Soares; Katie L Mason; Lisa M Rogers; Carlos H Serezani; Lucia H Faccioli; David M Aronoff
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

9.  HIV Infection and risk of postpartum infection, complications and mortality in rural Uganda.

Authors:  Lisa M Bebell; Joseph Ngonzi; Mark J Siedner; Winnie R Muyindike; Bosco M Bwana; Laura E Riley; Yap Boum; David R Bangsberg; Ingrid V Bassett
Journal:  AIDS Care       Date:  2018-02-16

10.  Intrauterine group A streptococcal infections are exacerbated by prostaglandin E2.

Authors:  Katie L Mason; Lisa M Rogers; Elyara M Soares; Tara Bani-Hashemi; John Erb Downward; Dalen Agnew; Marc Peters-Golden; Jason B Weinberg; Leslie J Crofford; David M Aronoff
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.